Sadaf Atiqi

Research output

Research output per year 2019 2022 2023 2024

• 8 Article
• 2 Comment/Letter to the editor

Research output per year

Research output per year

Search results

• 2024

  Changes in Tumor Necrosis Factor Inhibitor Drug Survival in Patients With Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis Over 15 Years

  Visman, I. M., Atiqi, S., Boers, M., Twisk, J. W. R. & Nurmohamed, M. T., 2024, In: Journal of rheumatology. 51, 1, p. 84-87 4 p.

  Research output: Contribution to journal › Article › Academic › peer-review
• 2023

  Drug-tolerant detection of anti-drug antibodies in an antigen-binding assay using europium chelate fluorescence

  van Strien, J., Dijk, L., Atiqi, S., Schouten, R., Bloem, K., Wolbink, G. J., Loeff, F. & Rispens, T., 1 Mar 2023, In: Journal of immunological methods. 514, 113436.

  Research output: Contribution to journal › Article › Academic › peer-review

• Novel DNA methylome biomarkers associated with adalimumab response in rheumatoid arthritis patients

  Hageman, I., Mol, F., Atiqi, S., Joustra, V., Sengul, H., Henneman, P., Visman, I., Hakvoort, T., Nurmohamed, M., Wolbink, G., Levin, E., Li Yim, A. Y. F., D’Haens, G. & de Jonge, W. J., 2023, In: Frontiers in immunology. 14, 1303231.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

• Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands

  Boekel, L., Atiqi, S., Leeuw, M., Hooijberg, F., Besten, Y. R., Wartena, R., Steenhuis, M., Vogelzang, E., Webers, C., Boonen, A., Gerritsen, M., Lems, W. F., Tas, S. W., van Vollenhoven, R. F., Voskuyl, A. E., van der Horst-Bruinsma, I., Nurmohamed, M., Rispens, T. & Wolbink, G., 1 Jul 2023, In: The Lancet Rheumatology. 5, 7, p. e375-e385

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  5 Citations (Scopus)
• 2022

  Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study

  Boekel, L., Hooijberg, F., Vogelzang, E. H., Besten, Y. R., Leeuw, M., Atiqi, S., van Vollenhoven, R. F., Wijbrandts, C. A., Gerritsen, M., Krieckaert, C., Dijkshoorn, B., Bakhlakh, S., Crooijmans, J. J., Voskuyl, A., van der Horst-Bruinsma, I. E., Lems, W., Kuijpers, T. W., van Ham, S. M., Wieske, L., Eftimov, F., & 13 othersKummer, L. Y., van Dam, P. K., Stalman, E. W., Steenhuis, M., Keijzer, S., Cristianawati, O., Keijser, J., Loeff, F. C., Tas, S. W., Nurmohamed, M. T., Boers, M., Rispens, T. & Wolbink, G., 5 Apr 2022, In: RMD OPEN. 8, 1, 002035.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  12 Citations (Scopus)

• Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies

  T2B! immunity against SARS-CoV-2 study group, 1 Jun 2022, In: The Lancet Rheumatology. 4, 6, p. e417-e429

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  34 Citations (Scopus)

• COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases

  Boekel, L., Hooijberg, F., Besten, Y. R., Vogelzang, E. H., Steenhuis, M., Leeuw, M., Atiqi, S., van Vollenhoven, R., Lems, W. F., Bos, W. H., Wijbrandts, C. A., Gerritsen, M., Krieckaert, C., Voskuyl, A. E., van der Horst-Bruinsma, I. E., Tas, S. W., Boers, M., Rispens, T., Nurmohamed, M. T. & Wolbink, G., 1 May 2022, In: The Lancet Rheumatology. 4, 5, p. e310-e313

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  12 Citations (Scopus)

• SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period

  Boekel, L., Besten, Y. R., Hooijberg, F., Wartena, R., Steenhuis, M., Vogelzang, E., Leeuw, M., Atiqi, S., Tas, S. W., Lems, W. F., van Ham, S. M., Eftimov, F., Stalman, E. W., Wieske, L., Kuijpers, T. W., Voskuyl, A. E., van Vollenhoven, R. F., Gerritsen, M., Krieckaert, C., Rispens, T., & 3 othersBoers, M., Nurmohamed, M. T. & Wolbink, G., 1 Nov 2022, In: The Lancet Rheumatology. 4, 11, p. e747-e750 4 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  8 Citations (Scopus)
• 2021

  Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch): study protocol for a fully blinded randomised superiority test-treatment trial: study protocol for a fully blinded randomised superiority test-treatment trial

  Wientjes, M. H. M., Atiqi, S., Wolbink, G. J., Nurmohamed, M. T., Boers, M., Rispens, T., de Vries, A., van Vollenhoven, R. F., van den Bemt, B. J. F. & den Broeder, A. A., 1 Dec 2021, In: Trials. 22, 1, p. 406 406.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  2 Citations (Scopus)
• 2019

  Diurnal rhythms in the white adipose tissue transcriptome are disturbed in obese individuals with type 2 diabetes compared with lean control individuals

  Stenvers, D. J., Jongejan, A., Atiqi, S., Vreijling, J. P., Limonard, E. J., Endert, E., Baas, F., Moerland, P. D., Fliers, E., Kalsbeek, A. & Bisschop, P. H., 1 Apr 2019, In: Diabetologia. 62, 4, p. 704-716

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  51 Citations (Scopus)